Mark J. Murray
Directeur/Bestuurslid bij Genevant Sciences Corp.
Profiel
Mark J.
Murray was the founder of Protiva Biotherapeutics, Inc. founded in 2000, where he held the title of President & Chief Executive Officer from 2000 to 2008.
Currently, he is a Director at Genevant Sciences Corp.
Dr. Murray's former position was at Arbutus Biopharma Corp.
where he held the title of President, Chief Executive Officer & Director from 2011 to 2019.
Dr. Murray received a doctorate degree from Oregon Health & Science University.
Actieve functies van Mark J. Murray
| Bedrijven | Functie | Begin |
|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mark J. Murray
| Bedrijven | Functie | Einde |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Algemeen Directeur | 24-06-2019 |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Algemeen Directeur | 02-12-2008 |
Opleiding van Mark J. Murray
| Oregon Health & Science University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
